RARE — Ultragenyx Pharmaceutical Inc
In 2026 Q2, 4 of the 140 tracked hedge funds reported a position in Ultragenyx Pharmaceutical Inc (RARE), worth $19.47M combined. Over the quarter 2 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $13.81M | 0.02% | -26.3% |
| BIT | $3.05M | 0.10% | +407.7% |
| Quadrature | $1.76M | 0.02% | -6.8% |
| IMC | $852.61K | 0.00% | +114.2% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.